Pancreatic Cancer Research

ResearcherUniversity of Hong KongNo recent work listed

Yibin Feng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0241-670X; OpenAlex author ID A5083377609. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Last author DOI 10.1016/j.apsb.2023.01.020↗
  2. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression. Last author DOI 10.1002/ctm2.467↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ning Wang · 2 shared papers, 2021–2023 · strength 0.34
  2. Chien‐shan Cheng · 2 shared papers, 2021–2023 · strength 0.34
  3. Yau-Tuen Chan · 1 shared paper, 2023 · strength 0.19
  4. Zhen Chen · 1 shared paper, 2021 · strength 0.15
  5. Zhiqiang Meng · 1 shared paper, 2021 · strength 0.15
  6. Lianyu Chen · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.